New Paradigms in Cancer Therapeutics (Z1) 2010
The advent of genome-scale profiling
technologies has opened up the possibility of comprehensively
monitoring multiple layers of molecular aberrations in cancer.
Alterations in the epigenome, genome, transcriptome, proteome and
metabolome have all been observed in tumor development. A number of key
molecular pathways have been found to be altered during cancer
progression. Pivotal questions in the field include: Can these novel
pathways alone or in combination be effectively targeted in cancer? Can
we identify molecular signatures that will facilitate personalized
medicine? What are the innovative therapeutic modalities that can be
employed to target these pathways? The goal of this meeting is to
tackle promising new targets for cancer therapy. These include targets
such as recurrent gene fusions, epigenetic pathways, and metabolic
networks. We will also explore the use of molecular marker panels to
select patients for treatment. A number of approaches to therapeutic
targeting will be discussed including novel biologics and RNA
interference.Dates
Mar 23,2010 - Mar 28,2010 (Ended)
Address
721 Government Street, BC.,
Victoria,
Canada
Victoria,
Canada
Prices *
520-845 US Dollar
Early registration
date
date
Jan 25,2010
Abstract submission
deadline
deadline
Dec 29,2009
Organization
Keystone Symposia
Categories
Health: Oncology
Important
Due to possible changes in conference details, we recommend that you check with the conference website, before making any traveling arrangements.
Due to possible changes in conference details, we recommend that you check with the conference website, before making any traveling arrangements.
* Prices are for evaluation only. For accurate prices, please check with conference website.
from €88.15*
